South Africa has put a hold on the rollout of the AstraZeneca COVID-19 vaccine.
Health Minister Dr Zweli Mkhize last night announced that a team of experts would give guidance on the way forward with this vaccine.
Early scientific data released on Sunday revealed that the vaccine offered “minimal protection” against mild disease for people infected with the second variant of the coronavirus discovered at the end of last year.
Clinical trial data from the AstraZeneca COVID-19 vaccine study locally revealed that it had a 22% efficacy against the 501Y.V2 coronavirus variant.
Minister Mkhize said that at the time that government acquired the vaccines, this clinical trial data had not been concluded.
More Stories
Goverment Plans New City Development Near Vaal River
Trump Investigated For Possible Violation Of Espionage Act
Kyrgios Win Streak Ended By Hurkacz in Canada
KZN Premier Dube-Ncube Reshuffles Cabinet
Ace Magashule’s Appeal Dismissed by the Constitutional Court
Delays in Zandile Gumede Corruption Case Enrages Judge
Ramaphosa Should Apologise Says Widows of Miners in Marikana
Zikalala Reinstated to the Executive in the KZN Legislature
The 3 Biggest Problems With Remote Work – What The Research Says
Are Old School Methods Of Saving Holding South Africans Back?
Affected Families Of Marikana Massacre To Get Update On Compensation
Suspects Arrested In Krugersdorp Due Back In Court